Adherence to Treatment With Tecfidera™ in Multiple Sclerosis Patients (ADIMS)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02099370
Recruitment Status :
First Posted : March 28, 2014
Last Update Posted : March 18, 2016
University of South Florida
Information provided by (Responsible Party):
Derrick Scott Robertson, University of South Florida
The investigators are measuring the adherence rates of an oral MS drug that is to be administered twice-daily. The investigators would like to observe any patterns that might indicate factors that greatly affect adherence.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
community sample of Multiple Sclerosis patients started on Tecfidera
Must give written informed consent and any authorizations required by local law (e.g., Protected Health Information [PHI]).
Aged 18 at the time of informed consent.
Must have a relapsing form of MS.
Male subjects and female subjects of child-bearing potential (including female subjects who are not post-menopausal for at least 1 year) must be willing to practice effective contraception (as defined by the investigator) during the study and be willing and able to continue contraception for 30 days after their last dose of study treatment.
Progressive form of MS
History of severe allergic or anaphylactic reactions or known drug hypersensitivity.
Female subjects considering becoming pregnant while in the study.
Female subjects who are currently pregnant or breast-feeding.
Unwillingness or inability to comply with the requirements of the protocol including the presence of any conditional (physical, mental or social) that is likely to affect the subject's ability to comply with the protocol.
Any other reason that, in opinion of the Investigator and/or the Sponsor, the subject is determined to be unsuitable for enrollment in this study.